DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,695,201 | +4.6% | 14,894 | +1.1% | 0.88% | +8.7% |
| Q2 2023 | $3,534,000 | -4.0% | 14,725 | +0.8% | 0.81% | -11.5% |
| Q1 2023 | $3,681,044 | -3.8% | 14,605 | +1.3% | 0.91% | -13.7% |
| Q4 2022 | $3,827,356 | +0.9% | 14,420 | -1.8% | 1.06% | -1.8% |
| Q3 2022 | $3,793,000 | +4.7% | 14,685 | +2.8% | 1.08% | +6.1% |
| Q2 2022 | $3,623,000 | -11.4% | 14,289 | +2.5% | 1.02% | +10.9% |
| Q1 2022 | $4,090,000 | -38.3% | 13,943 | -30.8% | 0.92% | -31.9% |
| Q4 2021 | $6,630,000 | +9.2% | 20,150 | +1.1% | 1.34% | -1.2% |
| Q3 2021 | $6,069,000 | +15.4% | 19,935 | +1.7% | 1.36% | +17.9% |
| Q2 2021 | $5,259,000 | +28.1% | 19,597 | +7.4% | 1.15% | +15.2% |
| Q1 2021 | $4,106,000 | +1.0% | 18,243 | -0.3% | 1.00% | -1.8% |
| Q4 2020 | $4,064,000 | +8.1% | 18,293 | +4.8% | 1.02% | -6.5% |
| Q3 2020 | $3,759,000 | +27.6% | 17,457 | +4.8% | 1.09% | +15.1% |
| Q2 2020 | $2,945,000 | +28.8% | 16,656 | +0.8% | 0.95% | +6.3% |
| Q1 2020 | $2,287,000 | -7.4% | 16,526 | +2.7% | 0.89% | +13.6% |
| Q4 2019 | $2,469,000 | +8.7% | 16,087 | +2.2% | 0.78% | +2.2% |
| Q3 2019 | $2,272,000 | +5.9% | 15,734 | +4.8% | 0.77% | +6.7% |
| Q2 2019 | $2,146,000 | +33.5% | 15,013 | +23.3% | 0.72% | +26.8% |
| Q1 2019 | $1,607,000 | +54.5% | 12,174 | +20.7% | 0.57% | +29.1% |
| Q4 2018 | $1,040,000 | +4.3% | 10,086 | +9.9% | 0.44% | +35.8% |
| Q3 2018 | $997,000 | +26.8% | 9,180 | +15.3% | 0.32% | +14.1% |
| Q2 2018 | $786,000 | +32.8% | 7,962 | +31.6% | 0.28% | +32.7% |
| Q1 2018 | $592,000 | – | 6,048 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |